Skip to main content

MoneyWorks4Me

Aurobindo Pharma informs about press release

21 Dec 2024 Evaluate
Aurobindo Pharma has informed that it enclosed copy of the Press Release that is being issued by the Company announcing that CuraTeQ Biologics s.r.o., a step-down subsidiary of the Company has obtained marketing authorisation from UK’s Medicines and Healthcare products Regulatory Agency (MHRA) for Bevqolva, its bevacizumab biosimilar version.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1762.95
Dr. Reddys Labs. 1338.50
Cipla 1357.00
Lupin 1998.00
Zydus Lifesciences 1186.00
View more..